-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $235

Benzinga·01/12/2026 09:46:01
Listen to the news
Needham analyst Ami Fadia maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and raises the price target from $210 to $235.